SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-038115
Filing Date
2019-02-13
Accepted
2019-02-13 16:44:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d660880d424b5.htm 424B5 312061
2 GRAPHIC g660880g65y11.jpg GRAPHIC 52772
  Complete submission text file 0001193125-19-038115.txt   385803
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228967 | Film No.: 19598135
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1